FDA Inspection 1274501 — Bayer Weimar GmbH Und Co. KG
The FDA completed an inspection of Bayer Weimar GmbH Und Co. KG on Nov 24, 2022 in Weimar. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 24, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Weimar (Germany)
Additional details
Mutual Recognition Agreement (MRA)